316 related articles for article (PubMed ID: 31019054)
1. Hepatitis B Virus Precore Protein p22 Inhibits Alpha Interferon Signaling by Blocking STAT Nuclear Translocation.
Mitra B; Wang J; Kim ES; Mao R; Dong M; Liu Y; Zhang J; Guo H
J Virol; 2019 Jul; 93(13):. PubMed ID: 31019054
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B Virus e Antigen Activates the Suppressor of Cytokine Signaling 2 to Repress Interferon Action.
Yu Y; Wan P; Cao Y; Zhang W; Chen J; Tan L; Wang Y; Sun Z; Zhang Q; Wan Y; Zhu Y; Liu F; Wu K; Liu Y; Wu J
Sci Rep; 2017 May; 7(1):1729. PubMed ID: 28496097
[TBL] [Abstract][Full Text] [Related]
3. In vitro expression of precore proteins of hepatitis B virus subgenotype A1 is affected by HBcAg, and can affect HBsAg secretion.
Deroubaix A; Kramvis A
Sci Rep; 2021 Apr; 11(1):8167. PubMed ID: 33854155
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen.
Jegaskanda S; Ahn SH; Skinner N; Thompson AJ; Ngyuen T; Holmes J; De Rose R; Navis M; Winnall WR; Kramski M; Bernardi G; Bayliss J; Colledge D; Sozzi V; Visvanathan K; Locarnini SA; Kent SJ; Revill PA
J Virol; 2014 Sep; 88(18):10412-20. PubMed ID: 24872585
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Hepatitis B Precore/Core-Related Antigens.
Hong X; Luckenbaugh L; Mendenhall M; Walsh R; Cabuang L; Soppe S; Revill PA; Burdette D; Feierbach B; Delaney W; Hu J
J Virol; 2021 Jan; 95(3):. PubMed ID: 33148795
[TBL] [Abstract][Full Text] [Related]
6. IFIT3 Is Increased in Serum from Patients with Chronic Hepatitis B Virus (HBV) Infection and Promotes the Anti-HBV Effect of Interferon Alpha via JAK-STAT2
Xu S; Huang J; Xun Z; Li S; Fu Y; Lin N; Wu W; Chen T; Liu C; Ou Q
Microbiol Spectr; 2022 Dec; 10(6):e0155722. PubMed ID: 36314949
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Intracellular Precore-Derived Proteins and Their Functions in Hepatitis B Virus-Infected Human Hepatocytes.
Hong X; Bianchini EN; Wang JC; Hu J
mBio; 2023 Feb; 14(1):e0350122. PubMed ID: 36715515
[TBL] [Abstract][Full Text] [Related]
8. Effects of interferon alpha therapy on the catalytic domains of the polymerase gene and basal core promoter, precore and core regions of hepatitis B virus.
Chen RY; Bowden S; Desmond PV; Dean J; Locarnini SA
J Gastroenterol Hepatol; 2003 Jun; 18(6):630-7. PubMed ID: 12753143
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B e Antigen Inhibits NF-κB Activity by Interrupting K63-Linked Ubiquitination of NEMO.
Wang Y; Cui L; Yang G; Zhan J; Guo L; Chen Y; Fan C; Liu D; Guo D
J Virol; 2019 Jan; 93(2):. PubMed ID: 30404796
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the serum alanine aminotransferase level at the end of interferon treatment and histologic changes in wild-type and precore mutant hepatitis B virus infections.
Bayraktar Y; Koseoglu T; Temizer A; Kayhan B; Van Thiel DH; Uzunalimoglu B
J Viral Hepat; 1996 May; 3(3):137-42. PubMed ID: 8871872
[TBL] [Abstract][Full Text] [Related]
11. Core promoter mutations of hepatitis B virus for the response to interferon in e antigen-positive chronic hepatitis B.
Kanai K; Kako M; Aikawa T; Hino K; Tsubouchi H; Takehira Y; Iwabuchi S; Kawasaki T; Tsuda F; Okamoto H; Miyakawa Y; Mayumi M
Am J Gastroenterol; 1996 Oct; 91(10):2150-6. PubMed ID: 8855739
[TBL] [Abstract][Full Text] [Related]
12. The impact of hepatitis B virus precore/core gene carboxyl terminal mutations on viral biosynthesis and the host immune response.
Wu JF; Ni YH; Chen HL; Hsu HY; Chang MH
J Infect Dis; 2014 May; 209(9):1374-81. PubMed ID: 24273041
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus polymerase inhibits the interferon-inducible MyD88 promoter by blocking nuclear translocation of Stat1.
Wu M; Xu Y; Lin S; Zhang X; Xiang L; Yuan Z
J Gen Virol; 2007 Dec; 88(Pt 12):3260-3269. PubMed ID: 18024894
[TBL] [Abstract][Full Text] [Related]
14. Amino acid residues at core protein dimer-dimer interface modulate multiple steps of hepatitis B virus replication and HBeAg biogenesis.
Liu H; Cheng J; Viswanathan U; Chang J; Lu F; Guo JT
PLoS Pathog; 2021 Nov; 17(11):e1010057. PubMed ID: 34752483
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B e antigen-negative mutations in the precore and core promoter regions in Korean patients.
Choi JW; Ahn SH; Park JY; Chang HY; Kim JK; Baatarkhuu O; Kim DY; Han KH; Chon CY
J Med Virol; 2009 Apr; 81(4):594-601. PubMed ID: 19235871
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan.
Chen CH; Lee CM; Lu SN; Changchien CS; Eng HL; Huang CM; Wang JH; Hung CH; Hu TH
J Clin Microbiol; 2005 Dec; 43(12):6000-6. PubMed ID: 16333089
[TBL] [Abstract][Full Text] [Related]
17. HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C.
Wai CT; Chu CJ; Hussain M; Lok AS
Hepatology; 2002 Dec; 36(6):1425-30. PubMed ID: 12447868
[TBL] [Abstract][Full Text] [Related]
18. Association between frequency of amino acid changes in core region of hepatitis B virus (HBV) and the presence of precore mutation in Japanese HBV carriers.
Karasawa T; Shirasawa T; Okawa Y; Kuramoto A; Shimada N; Aizawa Y; Zeniya M; Toda G
J Gastroenterol; 1997 Oct; 32(5):611-22. PubMed ID: 9349986
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-17A pretreatment attenuates the anti-hepatitis B virus efficacy of interferon-alpha by reducing activation of the interferon-stimulated gene factor 3 transcriptional complex in hepatitis B virus-expressing HepG2 cells.
Zhang J; Liu K; Zhang G; Ling N; Chen M
Virol J; 2022 Feb; 19(1):28. PubMed ID: 35144643
[TBL] [Abstract][Full Text] [Related]
20. Expression of Interferon Effector Gene SART1 Correlates with Interferon Treatment Response against Hepatitis B Infection.
Li Y; Zhu C; Wang F; Zhu T; Li J; Liu S; Xiao F
Mediators Inflamm; 2016; 2016():3894816. PubMed ID: 28077916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
